From Filter: Traditional treatment can pathologize normal behaviors of adolescence, thereby reinforcing stigma and existing low self-esteem.
From HealthDay: 'Patient influencers' are being seen as an increasingly popular direct-to-consumer marketing tool by pharmaceutical companies and medical device manufacturers.
From The Imprint: Screening for adverse childhood experiences has been met with growing concern among health researchers and child welfare experts, but the California surgeon general says it’s critical not to wait.
From The Daily Mail: Patients on antidepressants are not being warned of the risk that the pills could permanently ruin their sex lives, experts say.
From The Pharmaceutical Journal: The majority were males, and peaks in antidepressant prescribing to young people in England coincided with periods of lockdown during the COVID-19 pandemic.
From Dr. Gabor Maté: We need to look at the lives of today’s children and adolescents and, above all, at what’s missing in their lives.
From The New York Times: Future generations will look back on the tactics used in the troubled teen industry and ask: How did we allow these practices to pass off as mental health treatment for so long?
From The Mental Elf: Given their demonstrated harms and the fact there exist a number of alternatives, we should be asking whether antidepressants should be used at all in young people.
From Children's Health Defense: With warnings of a mental health crisis among young people, the recommendation may appear sound and reasonable—but depression screening can be dangerous, some experts say.